Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03272373 · ClinicalTrials.gov registry record · NA

NexGen TM Tibia Clinical Outcomes Study

A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.

Completed
Registry status
NA
Development phase
160
Enrollment target
7
Study locations

NCT03272373 is a NA study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by Zimmer Biomet. The registered enrollment target is 160 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03272373, a NA study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by Zimmer Biomet.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
7
Study locations

Study Summary

The objective of this study is to evaluate clinical performance for the commercially available NexGen TM Monoblock Tibia and NexGen TM Modular Tibia used in primary cementless tibia total knee arthroplasty.

Conditions Studied

Rheumatoid Arthritis Osteoarthritis Traumatic Arthritis Polyarthritis Collagen Disorders and/or Avascular Necrosis of the Femoral Condyle Post-traumatic Loss of Joint Configuration Moderate Valgus, Varus, or Flexion Deformities

Interventions

  • DEVICE NexGen TM Monoblock Tibia
  • DEVICE NexGen TM Modular Tibia

Study Locations (7)

Indiana

  • Franciscan Health - Mooresville
  • Henry County Orthopedics and Sports Medicine - New Castle

California

  • LA BioMed at Harbor-UCLA Medical Center - Torrance

Colorado

  • Cornerstone Orthopaedics & Sports Medicine, P.C. - Wheat Ridge

Missouri

  • Woods Mill Orthopedics, Ltd - Chesterfield

North Carolina

  • Pinehurst Surgical Clinic - Pinehurst

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2017-10-03
Est. Completion 2023-03-31
Phase NA

Sponsor

Zimmer Biomet

115 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03272373

The ClinicalTrials.gov registry entry for NCT03272373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which NexGen TM Monoblock Tibia is the first listed.

NCT03272373 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Indiana, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT03272373 about?

NCT03272373 is a clinical study titled "NexGen TM Tibia Clinical Outcomes Study". The objective of this study is to evaluate clinical performance for the commercially available NexGen TM Monoblock Tibia and NexGen TM Modular Tibia used in primary cementless tibia total knee arthroplasty.

What is the current status of trial NCT03272373?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2017-10-03. Estimated completion is 2023-03-31.

What conditions does trial NCT03272373 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Traumatic Arthritis, Polyarthritis, Collagen Disorders and/or Avascular Necrosis of the Femoral Condyle.

What interventions are being tested in trial NCT03272373?

The interventions under investigation include: NexGen TM Monoblock Tibia (DEVICE), NexGen TM Modular Tibia (DEVICE).

Who is sponsoring clinical trial NCT03272373?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03272373 being conducted?

This trial has 7 study locations across California, Colorado, Indiana, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

Osteoarthritis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.